A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by the FDA, and the partners have now withdrawn a filing intended to get the ...
Today's Top Tune is a free song each weekday curated for your listening pleasure, that represents a cross section of KCRW's eclectic music format. Tracks selected are chosen from recent and upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results